THE EFFECT OF PSYCHOTHERAPY AND STELAZINE® ON LENGTH OF HOSPITAL STAY, RELEASE RATE AND SUPPLEMENTAL TREATMENT OF SCHIZOPHRENIC PATIENTS

Publisher Website
Google Scholar
Abstract
A study of 80 first-admission schizophrenic patients suggests that, under state hospital conditions, the use of Steiazine shortens hospital stay, increases release rate, lessens the need to use sedatives and hydrotherapy, and is associated with a greater amount of change in overall clinical status. Individual psychotherapy alone, did not shorten hospital stay or increase release rate, although it may have, to a lesser extent, tended to diminish the need for supplemental measures and increase the amount of overall clinical change. There is a basis for speculation that individual psychotherapy and drugs combined may show an interaction effect. In combination, there may be additional shortening of hospital stay and increase in clinical improvement and release rate, but also, greater use of sedatives and hydrotherapy for certain patients. The mean length of hospital stay for control group patients released from the hospital was 187 days. This supports the view that evaluation periods in outcome research should conform to the natural history of the disease and that a period of at least 6 months is desirable for thorough evaluation of treatment outcome of first-admission schizophrenic patients in a state hospital setting.

This publication has 1 reference indexed in Scilit: